| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 259 | 2018 |
| Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study T Hagenacker, CD Wurster, R Günther, O Schreiber-Katz, A Osmanovic, ... The Lancet Neurology 19 (4), 317-325, 2020 | 244 | 2020 |
| TNF-α differentially modulates ion channels of nociceptive neurons JC Czeschik, T Hagenacker, M Schäfers, D Büsselberg Neuroscience letters 434 (3), 293-298, 2008 | 189 | 2008 |
| Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia T Hagenacker, V Bude, S Naegel, D Holle, Z Katsarava, HC Diener, ... The journal of headache and pain 15, 1-9, 2014 | 122 | 2014 |
| Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro M Schäfers, C Sommer, C Geis, T Hagenacker, P Vandenabeele, ... Neuroscience 157 (2), 414-423, 2008 | 107 | 2008 |
| Understanding the burden of refractory myasthenia gravis C Schneider-Gold, T Hagenacker, N Melzer, T Ruck Therapeutic advances in neurological disorders 12, 1756286419832242, 2019 | 104 | 2019 |
| Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis S Witzel, A Maier, R Steinbach, J Grosskreutz, JC Koch, A Sarikidi, S Petri, ... JAMA neurology 79 (2), 121-130, 2022 | 97 | 2022 |
| Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy B Stolte, A Totzeck, K Kizina, S Bolz, L Pietruck, C Mönninghoff, ... Therapeutic advances in neurological disorders 11, 1756286418803246, 2018 | 75 | 2018 |
| Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain C Geis, M Graulich, A Wissmann, T Hagenacker, J Thomale, C Sommer, ... Neuroscience 169 (1), 463-474, 2010 | 74 | 2010 |
| Prognostic factors in ALS: a comparison between Germany and China J Dorst, L Chen, A Rosenbohm, J Dreyhaupt, A Hübers, J Schuster, ... Journal of neurology 266, 1516-1525, 2019 | 67 | 2019 |
| Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons M Leo, LI Schmitt, M Erkel, M Melnikova, J Thomale, T Hagenacker Experimental neurology 288, 62-74, 2017 | 66 | 2017 |
| Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study JF Howard, S Bresch, A Genge, C Hewamadduma, J Hinton, Y Hussain, ... The Lancet Neurology 22 (5), 395-406, 2023 | 61 | 2023 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study V Bril, A Drużdż, J Grosskreutz, AA Habib, R Mantegazza, S Sacconi, ... The Lancet Neurology 22 (5), 383-394, 2023 | 61 | 2023 |
| Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II M Hartlehnert, A Derksen, T Hagenacker, D Kindermann, M Schäfers, ... Scientific reports 7 (1), 12518, 2017 | 61 | 2017 |
| Capsaicin differentially modulates voltage-activated calcium channel currents in dorsal root ganglion neurones of rats T Hagenacker, F Splettstoesser, W Greffrath, RD Treede, D Büsselberg Brain research 1062 (1-2), 74-85, 2005 | 61 | 2005 |
| Therapie und Verlauf neurologischer Erkrankungen B Schoser, JB Schulz, V Dietz, V Ghilescu, A Münchau, W Wick, U Bingel, ... Kohlhammer Verlag, 2023 | 57 | 2023 |
| Feedback mechanisms in the regulation of intracellular calcium ([Ca2+] i) in the peripheral nociceptive system: role of TRPV-1 and pain related receptors T Hagenacker, D Ledwig, D Büsselberg Cell calcium 43 (3), 215-227, 2008 | 51 | 2008 |
| Sensitization of voltage activated calcium channel currents for capsaicin in nociceptive neurons by tumor-necrosis-factor-α T Hagenacker, JC Czeschik, M Schäfers, D Büsselberg Brain research bulletin 81 (1), 157-163, 2010 | 50 | 2010 |
| Measuring outcomes in adults with spinal muscular atrophy–challenges and future directions–meeting report VA Sansone, MC Walter, S Attarian, S Delstanche, E Mercuri, ... Journal of neuromuscular diseases 7 (4), 523-534, 2020 | 49 | 2020 |
| Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients C Nelke, F Stascheit, C Eckert, M Pawlitzki, CB Schroeter, N Huntemann, ... Journal of neuroinflammation 19 (1), 89, 2022 | 48 | 2022 |
Dietrich BüsselbergWeill Cornell Medicine in QatarBestätigte E-Mail-Adresse bei qatar-med.cornell.edu
